Sign In

Login

Password

Forgot Password ? Sign Up

PD-1 (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "PD-1" in Czech language version.

refsWebsite
Global rank Czech rank
44doi.org
2nd place
4th place
42worldcat.org
5th place
3rd place
37nih.gov
4th place
8th place
3jimmunol.org
low place
5,054th place
3nature.com
234th place
72nd place
3elsevier.com
610th place
203rd place
2wiley.com
222nd place
83rd place
1uniprot.org
5,673rd place
4,035th place
1web.archive.org
1st place
1st place

doi.org

  • FIFE, Brian T.; PAUKEN, Kristen E. The role of the PD-1 pathway in autoimmunity and peripheral tolerance. Annals of the New York Academy of Sciences. 2011-01-01, roč. 1217, čís. 1, s. 45–59. Dostupné online [cit. 2018-01-25]. ISSN 1749-6632. doi:10.1111/j.1749-6632.2010.05919.x. (anglicky) 
  • FRANCISCO, Loise M.; SAGE, Peter T.; SHARPE, Arlene H. The PD-1 pathway in tolerance and autoimmunity. Immunological Reviews. 2010-07-01, roč. 236, čís. 1, s. 219–242. Dostupné online [cit. 2018-01-25]. ISSN 1600-065X. doi:10.1111/j.1600-065x.2010.00923.x. (anglicky) 
  • SYN, Nicholas L; TENG, Michele W L; MOK, Tony S K. De-novo and acquired resistance to immune checkpoint targeting. The Lancet Oncology. Roč. 18, čís. 12, s. e731–e741. Dostupné online [cit. 2018-01-24]. doi:10.1016/s1470-2045(17)30607-1. 
  • BARDHAN, Kankana; ANAGNOSTOU, Theodora; BOUSSIOTIS, Vassiliki A. The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation. Frontiers in Immunology. 2016-12-12, roč. 7. PMID: 28018338 PMCID: PMC5149523. Dostupné online [cit. 2018-01-24]. ISSN 1664-3224. doi:10.3389/fimmu.2016.00550. PMID 28018338. 
  • SHINOHARA, T.; TANIWAKI, M.; ISHIDA, Y. Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics. October 1994, roč. 23, čís. 3, s. 704–706. PMID: 7851902. Dostupné online [cit. 2018-01-24]. ISSN 0888-7543. doi:10.1006/geno.1994.1562. PMID 7851902. 
  • KEIR, Mary E.; BUTTE, Manish J.; FREEMAN, Gordon J. PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology. 2008, roč. 26, s. 677–704. PMID: 18173375. Dostupné online [cit. 2018-01-25]. ISSN 0732-0582. doi:10.1146/annurev.immunol.26.021607.090331. PMID 18173375. 
  • CHEMNITZ, Jens M.; PARRY, Richard V.; NICHOLS, Kim E. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation. The Journal of Immunology. 2004-07-15, roč. 173, čís. 2, s. 945–954. PMID: 15240681. Dostupné online [cit. 2018-02-15]. ISSN 0022-1767. doi:10.4049/jimmunol.173.2.945. PMID 15240681. (anglicky) 
  • BARBER, Daniel L.; WHERRY, E. John; MASOPUST, David. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006/02, roč. 439, čís. 7077, s. 682–687. Dostupné online [cit. 2018-02-13]. ISSN 1476-4687. doi:10.1038/nature04444. (En) 
  • RILEY, James L. PD-1 signaling in primary T cells. Immunological Reviews. May 2009, roč. 229, čís. 1, s. 114–125. PMID: 19426218 PMCID: PMC3424066. Dostupné online [cit. 2018-01-24]. ISSN 1600-065X. doi:10.1111/j.1600-065X.2009.00767.x. PMID 19426218. 
  • CHEMNITZ, Jens M.; PARRY, Richard V.; NICHOLS, Kim E. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation. The Journal of Immunology. 2004-07-15, roč. 173, čís. 2, s. 945–954. PMID: 15240681. Dostupné online [cit. 2018-01-25]. ISSN 0022-1767. doi:10.4049/jimmunol.173.2.945. PMID 15240681. (anglicky) 
  • NEEL, Benjamin G.; GU, Haihua; PAO, Lily. The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends in Biochemical Sciences. Roč. 28, čís. 6, s. 284–293. Dostupné online [cit. 2018-01-25]. doi:10.1016/s0968-0004(03)00091-4. 
  • KEIR, Mary E.; BUTTE, Manish J.; FREEMAN, Gordon J. PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology. 2008, roč. 26, s. 677–704. PMID: 18173375. Dostupné online [cit. 2018-02-07]. ISSN 0732-0582. doi:10.1146/annurev.immunol.26.021607.090331. PMID 18173375. 
  • ZHONG, Xuemei; TUMANG, Joseph R.; GAO, Wenda. PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. European Journal of Immunology. September 2007, roč. 37, čís. 9, s. 2405–2410. PMID: 17683117. Dostupné online [cit. 2018-01-25]. ISSN 0014-2980. doi:10.1002/eji.200737461. PMID 17683117. 
  • LATCHMAN, Y.; WOOD, C. R.; CHERNOVA, T. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nature Immunology. March 2001, roč. 2, čís. 3, s. 261–268. PMID: 11224527. Dostupné online [cit. 2018-02-06]. ISSN 1529-2908. doi:10.1038/85330. PMID 11224527. 
  • KEIR, Mary E.; BUTTE, Manish J.; FREEMAN, Gordon J. PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology. 2008, roč. 26, s. 677–704. PMID: 18173375. Dostupné online [cit. 2018-02-14]. ISSN 0732-0582. doi:10.1146/annurev.immunol.26.021607.090331. PMID 18173375. 
  • HE, Jiabei; HU, Ying; HU, Mingming. Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer. Scientific Reports. 2015-08-17, roč. 5, čís. 1. Dostupné online [cit. 2018-02-06]. ISSN 2045-2322. doi:10.1038/srep13110. (En) 
  • EPPIHIMER, Michael J.; GUNN, Jason; FREEMAN, Gordon J. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation (New York, N.Y.: 1994). April 2002, roč. 9, čís. 2, s. 133–145. PMID: 11932780 PMCID: PMC3740166. Dostupné online [cit. 2018-02-14]. ISSN 1073-9688. doi:10.1038/sj/mn/7800123. PMID 11932780. 
  • SCHREINER, Bettina; MITSDOERFFER, Meike; KIESEIER, Bernd C. Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Journal of Neuroimmunology. Roč. 155, čís. 1–2, s. 172–182. Dostupné online [cit. 2018-02-14]. doi:10.1016/j.jneuroim.2004.06.013. 
  • LEE, Seung-Jin; JANG, Byeong-Churl; LEE, Soo-Woong. Interferon regulatory factor-1 is prerequisite to the constitutive expression and IFN-gamma-induced upregulation of B7-H1 (CD274). FEBS letters. 2006-02-06, roč. 580, čís. 3, s. 755–762. PMID: 16413538. Dostupné online [cit. 2018-02-14]. ISSN 0014-5793. doi:10.1016/j.febslet.2005.12.093. PMID 16413538. 
  • LIU, Jizhong; HAMROUNI, Abdelbasset; WOLOWIEC, Darius. Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood. 2007-07-01, roč. 110, čís. 1, s. 296–304. PMID: 17363736. Dostupné online [cit. 2018-02-15]. ISSN 0006-4971. doi:10.1182/blood-2006-10-051482. PMID 17363736. 
  • PARSA, Andrew T.; WALDRON, James S.; PANNER, Amith. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nature Medicine. January 2007, roč. 13, čís. 1, s. 84–88. PMID: 17159987. Dostupné online [cit. 2018-02-14]. ISSN 1078-8956. doi:10.1038/nm1517. PMID 17159987. 
  • BARSOUM, Ivraym B.; SMALLWOOD, Chelsea A.; SIEMENS, D. Robert. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Research. 2014-02-01, roč. 74, čís. 3, s. 665–674. PMID: 24336068. Dostupné online [cit. 2018-02-14]. ISSN 1538-7445. doi:10.1158/0008-5472.CAN-13-0992. PMID 24336068. 
  • GATO-CAÑAS, Maria; ZUAZO, Miren; ARASANZ, Hugo. PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity. Cell Reports. 2017, roč. 20, čís. 8, s. 1818–1829. Dostupné online [cit. 2018-02-14]. doi:10.1016/j.celrep.2017.07.075. 
  • HUI, Enfu; CHEUNG, Jeanne; ZHU, Jing. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science (New York, N.Y.). 03 31, 2017, roč. 355, čís. 6332, s. 1428–1433. PMID: 28280247. Dostupné online [cit. 2018-02-12]. ISSN 1095-9203. doi:10.1126/science.aaf1292. PMID 28280247. 
  • SHEPPARD, Kelly-Ann; FITZ, Lori J.; LEE, Julie M. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS letters. 2004-09-10, roč. 574, čís. 1–3, s. 37–41. PMID: 15358536. Dostupné online [cit. 2018-02-05]. ISSN 0014-5793. doi:10.1016/j.febslet.2004.07.083. PMID 15358536. 
  • PATSOUKIS, Nikolaos; BROWN, Julia; PETKOVA, Victoria. Selective Effects of PD-1 on Akt and Ras Pathways Regulate Molecular Components of the Cell Cycle and Inhibit T Cell Proliferation. Science signaling. 2012-06-26, roč. 5, čís. 230, s. ra46. PMID: 22740686 PMCID: PMC5498435. Dostupné online [cit. 2018-02-05]. ISSN 1945-0877. doi:10.1126/scisignal.2002796. PMID 22740686. 
  • MATSUURA, Isao; DENISSOVA, Natalia G.; WANG, Guannan. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature. 2004/07, roč. 430, čís. 6996, s. 226–231. Dostupné online [cit. 2018-02-14]. ISSN 1476-4687. doi:10.1038/nature02650. (En) 
  • PARRY, Richard V.; CHEMNITZ, Jens M.; FRAUWIRTH, Kenneth A. CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms. Molecular and Cellular Biology. 2005-11, roč. 25, čís. 21, s. 9543–9553. PMID: 16227604 PMCID: PMC1265804. Dostupné online [cit. 2018-02-06]. ISSN 0270-7306. doi:10.1128/MCB.25.21.9543-9553.2005. PMID 16227604. 
  • CHEMNITZ, Jens M.; PARRY, Richard V.; NICHOLS, Kim E. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation. The Journal of Immunology. 2004-07-15, roč. 173, čís. 2, s. 945–954. PMID: 15240681. Dostupné online [cit. 2018-02-06]. ISSN 0022-1767. doi:10.4049/jimmunol.173.2.945. PMID 15240681. (anglicky) 
  • STARON, Matthew M.; GRAY, Simon M.; MARSHALL, Heather D. The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection. Immunity. Roč. 41, čís. 5, s. 802–814. Dostupné online [cit. 2018-02-13]. doi:10.1016/j.immuni.2014.10.013. 
  • MICHALEK, Ryan D.; GERRIETS, Valerie A.; JACOBS, Sarah R. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. Journal of Immunology (Baltimore, Md.: 1950). 2011-03-15, roč. 186, čís. 6, s. 3299–3303. PMID: 21317389 PMCID: PMC3198034. Dostupné online [cit. 2018-02-05]. ISSN 1550-6606. doi:10.4049/jimmunol.1003613. PMID 21317389. 
  • PATSOUKIS, Nikolaos; BARDHAN, Kankana; CHATTERJEE, Pranam. PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nature Communications. 2015-03-26, roč. 6. PMID: 25809635 PMCID: PMC4389235. Dostupné online [cit. 2018-02-05]. ISSN 2041-1723. doi:10.1038/ncomms7692. PMID 25809635. 
  • AMARNATH, Shoba; MANGUS, Courtney W.; WANG, James C. M. The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells. Science Translational Medicine. 2011-11-30, roč. 3, čís. 111, s. 111ra120–111ra120. PMID: 22133721. Dostupné v archivu pořízeném dne 2018-06-01. ISSN 1946-6234. doi:10.1126/scitranslmed.3003130. PMID 22133721. (anglicky) 
  • NURIEVA, Roza; THOMAS, Sunil; NGUYEN, Thang. T-cell tolerance or function is determined by combinatorial costimulatory signals. The EMBO Journal. 2006-06-07, roč. 25, čís. 11, s. 2623–2633. PMID: 16724117 PMCID: PMC1478197. Dostupné online [cit. 2018-02-14]. ISSN 0261-4189. doi:10.1038/sj.emboj.7601146. PMID 16724117. 
  • WANG, Xin; TENG, Feifei; KONG, Li. PD-L1 expression in human cancers and its association with clinical outcomes. OncoTargets and Therapy. 2016, roč. 9, s. 5023–5039. PMID: 27574444 PMCID: PMC4990391. Dostupné online [cit. 2019-02-10]. ISSN 1178-6930. doi:10.2147/OTT.S105862. PMID 27574444. 
  • GANDINI, Sara; MASSI, Daniela; MANDALÀ, Mario. PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 2016-4, roč. 100, s. 88–98. PMID: 26895815. Dostupné online [cit. 2019-02-10]. ISSN 1879-0461. doi:10.1016/j.critrevonc.2016.02.001. PMID 26895815. 
  • SYN, Nicholas L.; TENG, Michele W. L.; MOK, Tony S. K. De-novo and acquired resistance to immune checkpoint targeting. The Lancet. Oncology. 12 2017, roč. 18, čís. 12, s. e731–e741. PMID: 29208439. Dostupné online [cit. 2019-02-10]. ISSN 1474-5488. doi:10.1016/S1470-2045(17)30607-1. PMID 29208439. 
  • WEBER, Jeffrey. Immune checkpoint proteins: a new therapeutic paradigm for cancer--preclinical background: CTLA-4 and PD-1 blockade. Seminars in Oncology. 2010-10, roč. 37, čís. 5, s. 430–439. PMID: 21074057. Dostupné online [cit. 2019-02-10]. ISSN 1532-8708. doi:10.1053/j.seminoncol.2010.09.005. PMID 21074057. 
  • HERBST, Roy S.; SORIA, Jean-Charles; KOWANETZ, Marcin. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature. 2014-11-27, roč. 515, čís. 7528, s. 563–567. PMID: 25428504 PMCID: PMC4836193. Dostupné online [cit. 2019-02-10]. ISSN 1476-4687. doi:10.1038/nature14011. PMID 25428504. 
  • SNYDER, Alexandra; MAKAROV, Vladimir; MERGHOUB, Taha. Genetic basis for clinical response to CTLA-4 blockade in melanoma. The New England Journal of Medicine. 2014-12-04, roč. 371, čís. 23, s. 2189–2199. PMID: 25409260 PMCID: PMC4315319. Dostupné online [cit. 2019-02-10]. ISSN 1533-4406. doi:10.1056/NEJMoa1406498. PMID 25409260. 
  • BUCHBINDER, Elizabeth I.; DESAI, Anupam. CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition. American Journal of Clinical Oncology. 2016-2, roč. 39, čís. 1, s. 98–106. PMID: 26558876 PMCID: PMC4892769. Dostupné online [cit. 2019-02-10]. ISSN 1537-453X. doi:10.1097/COC.0000000000000239. PMID 26558876. 
  • TOPALIAN, Suzanne L.; TAUBE, Janis M.; ANDERS, Robert A. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nature Reviews. Cancer. 05 2016, roč. 16, čís. 5, s. 275–287. PMID: 27079802 PMCID: PMC5381938. Dostupné online [cit. 2019-02-10]. ISSN 1474-1768. doi:10.1038/nrc.2016.36. PMID 27079802. 
  • CHEN, Daniel S.; MELLMAN, Ira. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013-07-25, roč. 39, čís. 1, s. 1–10. PMID: 23890059. Dostupné online [cit. 2019-02-10]. ISSN 1097-4180. doi:10.1016/j.immuni.2013.07.012. PMID 23890059. 
  • CURRAN, Michael A.; MONTALVO, Welby; YAGITA, Hideo. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proceedings of the National Academy of Sciences of the United States of America. 2010-03-02, roč. 107, čís. 9, s. 4275–4280. PMID: 20160101 PMCID: PMC2840093. Dostupné online [cit. 2019-02-10]. ISSN 1091-6490. doi:10.1073/pnas.0915174107. PMID 20160101. 

elsevier.com

linkinghub.elsevier.com

  • SCHREINER, Bettina; MITSDOERFFER, Meike; KIESEIER, Bernd C. Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. Journal of Neuroimmunology. Roč. 155, čís. 1–2, s. 172–182. Dostupné online [cit. 2018-02-14]. doi:10.1016/j.jneuroim.2004.06.013. 
  • GATO-CAÑAS, Maria; ZUAZO, Miren; ARASANZ, Hugo. PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity. Cell Reports. 2017, roč. 20, čís. 8, s. 1818–1829. Dostupné online [cit. 2018-02-14]. doi:10.1016/j.celrep.2017.07.075. 
  • STARON, Matthew M.; GRAY, Simon M.; MARSHALL, Heather D. The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection. Immunity. Roč. 41, čís. 5, s. 802–814. Dostupné online [cit. 2018-02-13]. doi:10.1016/j.immuni.2014.10.013. 

jimmunol.org

  • CHEMNITZ, Jens M.; PARRY, Richard V.; NICHOLS, Kim E. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation. The Journal of Immunology. 2004-07-15, roč. 173, čís. 2, s. 945–954. PMID: 15240681. Dostupné online [cit. 2018-02-15]. ISSN 0022-1767. doi:10.4049/jimmunol.173.2.945. PMID 15240681. (anglicky) 
  • CHEMNITZ, Jens M.; PARRY, Richard V.; NICHOLS, Kim E. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation. The Journal of Immunology. 2004-07-15, roč. 173, čís. 2, s. 945–954. PMID: 15240681. Dostupné online [cit. 2018-01-25]. ISSN 0022-1767. doi:10.4049/jimmunol.173.2.945. PMID 15240681. (anglicky) 
  • CHEMNITZ, Jens M.; PARRY, Richard V.; NICHOLS, Kim E. SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation. The Journal of Immunology. 2004-07-15, roč. 173, čís. 2, s. 945–954. PMID: 15240681. Dostupné online [cit. 2018-02-06]. ISSN 0022-1767. doi:10.4049/jimmunol.173.2.945. PMID 15240681. (anglicky) 

nature.com

  • BARBER, Daniel L.; WHERRY, E. John; MASOPUST, David. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006/02, roč. 439, čís. 7077, s. 682–687. Dostupné online [cit. 2018-02-13]. ISSN 1476-4687. doi:10.1038/nature04444. (En) 
  • HE, Jiabei; HU, Ying; HU, Mingming. Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer. Scientific Reports. 2015-08-17, roč. 5, čís. 1. Dostupné online [cit. 2018-02-06]. ISSN 2045-2322. doi:10.1038/srep13110. (En) 
  • MATSUURA, Isao; DENISSOVA, Natalia G.; WANG, Guannan. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature. 2004/07, roč. 430, čís. 6996, s. 226–231. Dostupné online [cit. 2018-02-14]. ISSN 1476-4687. doi:10.1038/nature02650. (En) 

nih.gov

ncbi.nlm.nih.gov

uniprot.org

  • PDCD1 - Programmed cell death protein 1 precursor - Homo sapiens (Human) - PDCD1 gene & protein. www.uniprot.org [online]. [cit. 2018-01-25]. Dostupné online. (anglicky) 

web.archive.org

wiley.com

onlinelibrary.wiley.com

worldcat.org